Cargando…
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
The endocannabinoid system (ECS) has been placed in the anti-cancer spotlight in the last decade. The immense data load published on its dual role in both tumorigenesis and inhibition of tumor growth and metastatic spread has transformed the cannabinoid receptors CB1 (CB1R) and CB2 (CB2R), and other...
Autores principales: | Moreno, Estefanía, Cavic, Milena, Krivokuca, Ana, Casadó, Vicent, Canela, Enric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459931/ https://www.ncbi.nlm.nih.gov/pubmed/31024307 http://dx.doi.org/10.3389/fphar.2019.00339 |
Ejemplares similares
-
The Interplay between Cancer Biology and the Endocannabinoid System—Significance for Cancer Risk, Prognosis and Response to Treatment
por: Moreno, Estefanía, et al.
Publicado: (2020) -
Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System—Implications for Health and Disease
por: Moreno, Estefanía, et al.
Publicado: (2021) -
Molecular Evidence of Adenosine Deaminase Linking Adenosine A(2A) Receptor and CD26 Proteins
por: Moreno, Estefanía, et al.
Publicado: (2018) -
Editorial: The Canonical and Non-Canonical Endocannabinoid System as a Target in Cancer and Acute and Chronic Pain
por: Contino, Marialessandra, et al.
Publicado: (2020) -
The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation
por: Young, Alexander P., et al.
Publicado: (2022)